Anyone conducting CIT studies can and WOULD publish the results without revealing any information about Radient's "technology, business and production."
"the information regarding technology, business and production of the other Party to which that Party had access by executing and performing this Agreement" does not have ANYTHING to do with Phase II studies or Phase III studies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.